Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2004

Jan 26, 2004

29777_dirs_2004-01-26_d7d21479-28fb-4332-ba4a-04b89ffd42e1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2003-07-16

Reporting Person: FREYMAN THOMAS C (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2003-07-16 Common shares without par value G 480 Disposed 155614 Direct
2004-01-22 Common shares without par value M 10216 $19.57 Acquired 165830 Direct
2004-01-22 Common shares without par value M 26666 $34.70 Acquired 192496 Direct
2004-01-22 Common shares without par value F 27773 $43.70 Disposed 164723 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2004-01-22 Option (right to buy) $19.57 M 10216 Disposed 2005-04-27 Common shares (10216) Direct
2004-01-22 Option (right to buy) $34.70 M 26666 Disposed 2010-02-10 Common shares (26666) Direct
2004-01-22 Option (right to buy) $43.70 A 23199 Acquired 2010-02-10 Common shares (23199) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 15903 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of January 22, 2004.

F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.